{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:38:16Z","timestamp":1761100696079},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2004,4,5]],"date-time":"2004-04-05T00:00:00Z","timestamp":1081123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,4,5]],"date-time":"2004-04-05T00:00:00Z","timestamp":1081123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,5,1]]},"DOI":"10.1038\/sj.bmt.1704488","type":"journal-article","created":{"date-parts":[[2004,4,5]],"date-time":"2004-04-05T09:11:18Z","timestamp":1081156278000},"page":"1037-1041","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Successful treatment of incipient graft rejection with donor leukocyte infusions, further proof of a graft versus host lymphohaemopoietic effect"],"prefix":"10.1038","volume":"33","author":[{"given":"J L","family":"D\u00edez-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"G\u00f3mez-Pineda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Balsalobre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Bu\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,4,5]]},"reference":[{"key":"BF1704488_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1056\/NEJM199403243301206","volume":"330","author":"J Armitage","year":"1994","unstructured":"Armitage J . Bone marrow transplantation. New Eng J Med 1994; 330: 827\u2013838.","journal-title":"New Eng J Med"},{"key":"BF1704488_CR2","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","volume":"78","author":"A Marmont","year":"1991","unstructured":"Marmont A, Horowitz MM, Gale RP et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120\u20132130.","journal-title":"Blood"},{"key":"BF1704488_CR3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.7326\/0003-4819-108-6-806","volume":"108","author":"JM Goldman","year":"1988","unstructured":"Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse with T-cell depletion. Ann Int Med 1988; 108: 806\u2013814.","journal-title":"Ann Int Med"},{"key":"BF1704488_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2141.1986.tb05544.x","volume":"63","author":"J Patterson","year":"1986","unstructured":"Patterson J, Prentice HG, Brenner MK et al. Graft rejection following HLA-matched T-lymphocyte depleted bone marrow transplantation. Br J Haematol 1986; 63: 221\u2013230.","journal-title":"Br J Haematol"},{"key":"BF1704488_CR5","first-page":"603","volume-title":"Haematopoietic Stem Cell Therapy","author":"J Chen","year":"2000","unstructured":"Chen J, Law P, Ball ED . Late graft failure. In: Ball ED, Lister J, Law P (eds.). Haematopoietic Stem Cell Therapy. Churchill Livingstone, London, 2000; pp 603\u2013607."},{"key":"BF1704488_CR6","first-page":"45","volume":"9","author":"SN Wolff","year":"2002","unstructured":"Wolff SN . Second haematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002; 9: 45\u201352.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704488_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1053\/bbmt.2001.v7.pm11669214","volume":"7","author":"JH Antin","year":"2001","unstructured":"Antin JH, Childs R, Filipovich AH et al. Establishment of complete and mixed donor chimaerism after allogeneic lymphohemopoietic transplantation: Recommendations from a workshop at the 2001 Tandem Meetings. Biol Blood Marrow Transplant 2001; 7: 473\u2013485.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704488_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/1042819031000067738","volume":"44","author":"I Bu\u00f1o","year":"2003","unstructured":"Bu\u00f1o I, Anta B, Moreno-L\u00f3pez E et al. Lineage-specific chimaerism quantification after T-cell depleted peripheral blood stem cell transplantation. Leuk Lymphoma 2003; 44: 659\u2013667.","journal-title":"Leuk Lymphoma"},{"key":"BF1704488_CR9","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/sj.leu.2401603","volume":"13","author":"J Dubovski","year":"1999","unstructured":"Dubovski J, Daxberger H, Fritsch G et al. Kinetics of chimaerism during the early post-transplant period in pediatric patients with malignant and non-malignant haematologic disorders: implications for a timely detection of engraftment, graft failure and rejection. Leukemia 1999; 13: 2060\u20132069.","journal-title":"Leukemia"},{"key":"BF1704488_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1182\/blood.V97.2.383","volume":"97","author":"A Urbano-Ispizua","year":"2001","unstructured":"Urbano-Ispizua A, Rozman C, Pimentel P et al. The number of CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings. Blood 2001; 97: 383\u2013387.","journal-title":"Blood"},{"key":"BF1704488_CR11","first-page":"2227","volume":"74","author":"NA Kernan","year":"1989","unstructured":"Kernan NA, Bordignon C, Heller G et al. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood 1989; 74: 2227\u20132236.","journal-title":"Analysis of risk factors and results of secondary transplants. Blood"},{"key":"BF1704488_CR12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V91.3.1083","volume":"91","author":"ED Papadopoulos","year":"1998","unstructured":"Papadopoulos ED, Carabasi MH, Castro-Malaspina H et al. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood 1998; 91: 1083\u20131090.","journal-title":"Blood"},{"key":"BF1704488_CR13","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","volume":"339","author":"F Aversa","year":"1998","unstructured":"Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. New Eng J Med 1998; 339: 1186\u20131193.","journal-title":"New Eng J Med"},{"key":"BF1704488_CR14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood.V73.2.606.606","volume":"73","author":"RE Champlin","year":"1989","unstructured":"Champlin RE, Horowitz MM, van Bekkum DW et al. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood 1989; 73: 606\u2013613.","journal-title":"Blood"},{"key":"BF1704488_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/bbmt.1999.v5.pm10465099","volume":"5","author":"P McSweeney","year":"1999","unstructured":"McSweeney P, Storb R . Mixed chimaerism: preclinical studies and clinical applications. Biol Blood Marrow Transplant 1999; 5: 192\u2013203.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704488_CR16","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.V94.9.3234","volume":"94","author":"R Childs","year":"1999","unstructured":"Childs R, Clave E, Contentin N et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimaerism precedes alloimmune responses. Blood 1999; 94: 3234\u20133241.","journal-title":"Blood"},{"key":"BF1704488_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00007890-199007000-00038","volume":"50","author":"CS Higano","year":"1990","unstructured":"Higano CS, Brixey M, Bryant EM et al. Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosupression following relapse after allogeneic bone marrow transplantation. Transplantation 1990; 50: 175\u2013177.","journal-title":"Transplantation"},{"key":"BF1704488_CR18","first-page":"405","volume-title":"Hematology 1999","author":"M Sykes","year":"1999","unstructured":"Sykes M, Sachs D, Spitzer T . Mixed chimaerism followed by DLI for lymphohaematopoietic GVH reactions without GVHD: from animal models to patients. In: Schechter GP, Hoffman R, Schrier SL, Bajus JL (eds.) Hematology 1999. American Society of Hematology, Washington, 1999; pp 405\u2013412."},{"key":"BF1704488_CR19","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfussions in marrow grafted patients. Blood 1995; 86: 2041\u20132050.","journal-title":"Blood"},{"key":"BF1704488_CR20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1056\/NEJM200103223441203","volume":"344","author":"ME Horwitz","year":"2001","unstructured":"Horwitz ME, Barrett AJ, Brown MR et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell depleted hematopoietic allograft. N Engl J Med 2001; 344: 881\u2013888.","journal-title":"N Engl J Med"},{"key":"BF1704488_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.bmt.1701131","volume":"21","author":"AJ Barrett","year":"1998","unstructured":"Barrett AJ, Mavroudis D, Tisdale J et al. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect. Bone Marrow Transplant 1998; 21: 543\u2013551.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704488_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/00043426-199803000-00011","volume":"20","author":"M Aker","year":"1998","unstructured":"Aker M, Kapelushnik J, Pugatsch T et al. Donor lymphocyte infusions to displace residual host haematopoietic cells after allogeneic bone marrow transplantation for B-thalassemia major. J Pediatric Hematol Oncol 1998; 20: 145\u2013148.","journal-title":"J Pediatric Hematol Oncol"},{"key":"BF1704488_CR23","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1046\/j.1537-2995.2000.40091071.x","volume":"40","author":"F Baron","year":"2000","unstructured":"Baron F, Dresse MF, Beguin Y . Donor lymphocyte infusion to eradicate recurrent host haematopoiesis after allogeneic BMT for sickle cell disease. Transfusion 2000; 40: 1071\u20131073.","journal-title":"Transfusion"},{"key":"BF1704488_CR24","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/sj.bmt.1703922","volume":"31","author":"UM Saarinen-Pihkala","year":"2003","unstructured":"Saarinen-Pihkala UM, Taskinen M, Vettenranta K, Hovi L . Inminent allograft rejection prevented by donor leukocyte infusions: report of two paediatric cases. Bone Marrow Transplant 2003; 31: 833\u2013836.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704488_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3109\/10428199909167392","volume":"32","author":"A Schattenberg","year":"1999","unstructured":"Schattenberg A, Schaap N, Van De Wiel-Van Kemenade E et al. In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusion. Leuk Lymphoma 1999; 32: 317\u2013325.","journal-title":"Leuk Lymphoma"},{"key":"BF1704488_CR26","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood.V89.9.3113","volume":"89","author":"F Keil","year":"1997","unstructured":"Keil F, Haas OA, Fritsch G et al. Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor haematopoiesis predicts aplasia. Blood 1997; 89: 3113\u20133117.","journal-title":"Blood"},{"key":"BF1704488_CR27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","volume":"86","author":"S Mackinnon","year":"1995","unstructured":"Mackinnon S, Papadopoulos EB, Caralasi MH et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261\u20131268.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704488","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:43:13Z","timestamp":1648078993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,5]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,5,1]]}},"alternative-id":["BF1704488"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704488","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,5]]},"assertion":[{"value":"19 September 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}